Cardinal Health Raises EPS Forecast for Fiscal Year 2025 and Sees Growth Opportunities Despite Tariff Risks

The US company is one of the world's leading wholesalers in pharmaceuticals and medical technology. The adjusted earnings per share rose by 13% to $2.35 in the third quarter, surpassing estimates. The adjusted operating profit increased by 21% to $807 million. Cardinal Health expects further momentum from the acquisition of Specialty Networks, completed earlier this year. Cardinal Health (NYSE: CAH) is a leading pharmaceutical wholesaler engaged in the procurement and distribution of branded, generic, and specialty pharmaceutical products...